Back to search

Article

Targeted epigenetic repression of oncogenic transcription factors via CRISPR/dCas9 locus-specific silencing

2026-06-27

Abstract excerpt

Despite the revolutionary impact of genome engineering tools in medicine, the safe and effective intracellular delivery of CRISPR remains a major obstacle for clinical applications. Here, we implement precision molecular medicine and delivery strategies based on CRISPR/dCas9 systems adapted for epigenetic repression (dCas9-KRAB) to silence oncogenic drivers with high genomic selectivity. As proof-of-principle, we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ae597921-8365-59aa-baf1-da1919086ff2
DOI
10.64898/2026.06.27.734664
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted epigenetic repression of oncogenic transcription factors via CRISPR/dCas9 locus-specific silencingDOI 10.64898/2026.06.27.734664
Select a neighboring publication to make it the new centre.